Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease

Liver International : Official Journal of the International Association for the Study of the Liver
Emanuela TestaRoberto Testa

Abstract

To evaluate the relationship between hyaluronic acid/aminopyrine breath test (HA/ABT) ratio and fibrosis score in chronic hepatitis, and between HA/ABT and clinical staging (child-turcotte-pugh'score, CTP; and model for end stage liver disease, MELD) in cirrhosis, as well as to evaluate the aspartate aminotransferase (AST)/ABT in relation to the HA/ABT. We studied 48 patients with histologically proven chronic hepatitis C (CHC) and 35 patients with compensated cirrhosis (CIR). HA/ABT and AST/ABT showed a more significant correlation with the fibrosis score than HA or ABT or AST alone in the 48 CHC patients: r=0.568 (P<0.0001), r=0.610 (P<0.0001), r=0.450 (P=0.0021), r=-0.449 (P=0.0021), and r=0.472(P=0.0012), respectively. Progressive liver damage (fibrosis 1-2 vs fibrosis 3-6 vs cirrhosis) was significantly (P<0.05) reflected by both HA/ABT (mean+/-SEM: 4.0+/-0.9 vs 18.1+/-4.2 vs 149.9+/-33.1) and AST/ABT (6.3+/-1.8 vs 12.7+/-1.6 vs 42.1+/-14.6). A strong relationship was found between HA/ABT and AST/ABT (r=0.755 P<0.0001). In cirrhotic patients, the most significant relationship was observed between HA/ABT and CTP r=0.483 and P=0.0049, and MELD r=0.523 and P=0.0023. Considering that HA levels in chronic hepatitis depend on th...Continue Reading

References

Jun 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P R GibsonF J Dudley
May 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y KamimotoY Morino
Mar 1, 1983·Experimental Cell Research·S ErikssonB Smedsrød
Jun 1, 1995·Journal of Hepatology·K IshakR N MacSween
Sep 1, 1994·Clinical Pharmacokinetics·J Brockmöller, I Roots
Aug 1, 1993·Gastroenterology·T UenoM Sata
Jul 1, 1997·Journal of Internal Medicine·J R FraserU B Laurent
Nov 14, 1997·Gastroenterology·F ObertiP Calès
Jul 2, 1999·Digestive Diseases and Sciences·E GianniniR Testa
Mar 29, 2000·Journal of Hepatology·J GuéchotR Poupon
Jul 25, 2000·European Journal of Clinical Investigation·U LindqvistB Långström
Oct 19, 2002·The American Journal of Gastroenterology·Arie RegevEugene R Schiff
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick MarcellinNathalie Boyer
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kelly A GeboEric B Bass
Jan 4, 2003·Gastroenterology·Marc G GhanyJay H Hoofnagle
Feb 20, 2003·Journal of Hepatology·Alfredo Alberti, Luisa Benvegnù
Mar 26, 2003·Liver International : Official Journal of the International Association for the Study of the Liver·Anna M WilliamsRobin D Hughes
Dec 4, 2003·Journal of Hepatology·Thomas KörnerAxel M Gressner
Sep 7, 2004·Expert Review of Molecular Diagnostics·Ralf Lichtinghagen, Matthias J Bahr
Dec 4, 2004·Gastroenterology·William M C RosenbergUNKNOWN European Liver Fibrosis Group
Mar 22, 2005·Journal of Hepatology·Massimo PinzaniStefano Colagrande
Jun 11, 2005·Journal of Gastroenterology and Hepatology·Adam GordonStuart K Roberts
Jul 7, 2005·Liver International : Official Journal of the International Association for the Study of the Liver·Ayako SuzukiKeith Lindor

❮ Previous
Next ❯

Citations

Oct 31, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Sebastian BernuthTim Zimmermann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.